For increasing the price of subsidised medicine

The federal government should increase the amount that patients pay for medicine under the Pharmaceutical Benefits Scheme (PBS) and the Repatriation Pharmaceutical Benefits Scheme (known as the 'co-payment')

3 relevant divisions

Voted very strongly for increasing the price of subsidised medicine

What does this mean?

Voted moderately for increasing the price of subsidised medicine

What does this mean?

Voted moderately against increasing the price of subsidised medicine

What does this mean?

Voted very strongly against increasing the price of subsidised medicine

What does this mean?

Never voted on increasing the price of subsidised medicine

What does this mean?

Relevant divisions

See detail

These divisions relate to the policy “for increasing the price of subsidised medicine”. Compare how a supporter of the policy would have voted to the division outcome.

Division Supporters vote Division outcome

16th Jul 2014, 6:36 PM – Representatives National Health Amendment (Pharmaceutical Benefits) Bill 2014 — Third Reading — Read a third time

Yes (strong) Passed by a small majority

16th Jul 2014, 6:05 PM – Representatives National Health Amendment (Pharmaceutical Benefits) Bill 2014 — Consideration in Detail — Agree to the bill

Yes (strong) Passed by a small majority

16th Jul 2014, 4:30 PM – Representatives National Health Amendment (Pharmaceutical Benefits) Bill 2014 — Second Reading — Read a second time

Yes (strong) Passed by a small majority

If you know of other divisions that relate to this policy, you can add them in the Votes section of that division‘s page.